SARAH PURCELL: Open Payments
NPI 1104344043 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,421 in 116 payments from 41 companies in 2025. Trend: 2023 $1,099 · 2024 $1,600 · 2025 $2,421
Food & beverage: $2,421
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $280 |
| AstraZeneca Pharmaceuticals LP | 11 | $239 |
| Janssen Biotech, Inc. | 11 | $203 |
| Novartis Pharmaceuticals Corporation | 7 | $181 |
| Daiichi Sankyo Inc. | 8 | $168 |
| Celgene Corporation | 6 | $105 |
| Merck Sharp & Dohme LLC | 4 | $99 |
| Exelixis Inc. | 4 | $90 |
| BeOne Medicines USA, Inc. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
Products named: LIBTAYO, KISQALI, Enhertu, RYBREVANT, CABOMETYX, AYVAKIT, ERLEADA, KEYTRUDA.
Industry payments across TN — which companies pay providers there.
